BioCryst Pharmaceuticals shares owned by Robert Bender & Associates
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Robert Bender & Associates
from 13F filings
Historical chart of Robert Bender & Associates investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Robert Bender & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Robert Bender & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $180k | 24k | 7.59 |
| 2025-06-30 | $212k | 24k | 8.96 |
| 2024-12-31 | $178k | 24k | 7.52 |
| 2023-12-31 | $339k | 57k | 5.99 |
| 2023-09-30 | $401k | 57k | 7.08 |
| 2023-06-30 | $483k | 69k | 7.04 |
| 2023-03-31 | $572k | 69k | 8.34 |
| 2022-09-30 | $864k | 69k | 12.59 |
| 2022-06-30 | $726k | 69k | 10.58 |
More positions owned by Robert Bender & Associates
View all positions for Robert Bender & Associates